An online prescription is only one step in getting treatment. Someone must review the health history, decide whether prescribing is appropriate, prepare the medicine, arrange delivery and answer questions afterward. Willow markets a convenient, fully online route through those steps, with compounded semaglutide and tirzepatide, physician messaging and shipping bundled into plans starting at $299 per month. The practical question is how clearly its documentation explains who handles each part—and what happens when a handoff does not go as expected.
This review examines Willow’s public documentation consulted October 19, 2026, rather than firsthand treatment experience. Willow documents an actual GLP-1 program, including injectable and oral sublingual offerings, but it describes itself as a technology platform, not the medical practice or pharmacy. That distinction shapes the entire service. Its pages provide useful detail about intake, pharmacy processing and cancellation, while leaving unresolved questions about specific clinical entities, prescription assignment and conflicting insurance-reimbursement language.
At a glance
- Care model
- Willow is a technology platform connecting patients with physicians and pharmacies; its terms say it is neither a healthcare provider nor a pharmacy.Sources: [4]
- Starting price
- Plans start at $299 per month with medication, evaluation, a treatment plan, physician access, support and shipping; prescription-specific prices can be higher.
- Availability
- Willow’s FAQ lists 36 states. Its terms also require the patient to be physically in a state where the relevant professionals and pharmacy are authorized.
- Delivery sequence
- After physician review and prescribing, pharmacy processing takes 2–4 business days; delivery after shipment typically takes another 2–3 days via FedEx or UPS.Sources: [6]
- Renewal and cancellation
- Programs renew automatically. Requests to avoid the next charge must arrive at least two business days before the next processing date; the published full-refund condition is cancellation before the prescription is sent to the pharmacy.Sources: [6]
Start by identifying who is responsible for care
Willow’s terms identify the operating company as Willow Health Services, Inc., with a Houston, Texas, address. They say physicians employed by or contracted with affiliated medical practices provide consultations. Willow states that it neither owns those practices nor controls their practice of medicine. This is more than corporate fine print: the platform, prescribing practice and dispensing pharmacy have different responsibilities, even when patients experience them through one website and payment process.
The consulted documentation does not identify the affiliated medical practices by legal name. Willow’s institutional page presents Michael Green as chief medical officer and describes him as a dual board-certified physician with more than 30 years of experience. Those are provider statements, not independently verified credentials. Before enrolling, a useful request is the legal name of the practice responsible for the consultation and the identity of the professional who will review the intake.
The distinction also helps route questions appropriately. A billing question may belong with Willow’s care team, a prescription decision with the physician, and a preparation or shipment concern with the pharmacy. Our guide to clinicians and telehealth platforms explains that division of responsibilities. Willow documents the broad structure, but the patient-specific connection between those organizations becomes important once an actual prescription and pharmacy assignment exist.
Intake is a clinical review, not a prescription guarantee
Willow describes the initial virtual consultation as a short online form covering health, lifestyle and medical history. A licensed physician reviews that information, develops a personalized plan and prescribes only if the patient is eligible. The homepage says review usually occurs within 24 hours. That is a stated review expectation, not a guarantee of approval, dispatch or delivery. The terms explicitly say completing intake, paying or subscribing does not guarantee a prescription, particular medication or refill.
Published entry criteria include being at least 18, not being pregnant or breastfeeding, and living in a served state. Willow lists an eating disorder, recent bariatric surgery, gallbladder disease, pancreatitis, and a history of medullary thyroid cancer or MEN2 among its exclusions. It also says it currently cannot accept people with diabetes, while people with prediabetes or hypertension may be considered. These are Willow’s program criteria, not a substitute for an individual medical assessment.
Willow says its eligibility list is not exhaustive and that physicians evaluate each person. The consulted pages do not establish a provider-specific BMI threshold or a complete mandatory laboratory-testing protocol. Patients can therefore use intake to ask what additional information, testing or consultation will be required before prescribing. NIDDK’s general guidance supports discussing medicines, supplements, allergies and pregnancy plans with the clinician; none of those discussions should be replaced by assumptions based on a website checklist.
Confirm the exact formulation before the pharmacy handoff
Willow documents compounded semaglutide and tirzepatide in injectable and oral sublingual forms. Its semaglutide product page describes a once-weekly injection and also describes a blend with cyanocobalamin, or vitamin B12; that description does not establish the composition of every prescription. Its tirzepatide page describes a customized compounded formulation developed with the Willow physician. The ingredient name alone therefore does not tell a patient the route, blend or presentation that will actually be prescribed.
The safety documentation also identifies a combined semaglutide/tirzepatide oral dissolvable tablet. Willow acknowledges that established safety data for the combination do not extend beyond what is known for each ingredient individually. Its help center says no FDA-approved oral-dissolving formulation of semaglutide or tirzepatide exists and that Willow is not the manufacturer. These distinctions deserve a direct conversation about the proposed product rather than treating all offerings as interchangeable versions of one medicine.
FDA approval applies to a specific product, not to Willow as a platform. Compounded preparations are not FDA approved and do not undergo FDA premarket review for safety, effectiveness and quality; that fact alone does not establish clinical inequivalence. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug. Our formulation-check guide offers questions about route, ingredients and pharmacy. Willow’s injection-related claims should not be read as evidence for its sublingual or combination products.
The pharmacy network is named, but individual assignment is not
Willow’s terms list several pharmacy partners: Red Rock Home Pharmacy in Springville, Utah; Epiq Pharmacy, identified as Epiq Scripts LLC, in Richardson, Texas; Absolute Pharmacy in Lutz, Florida; The Pharmacy Hub in Miami; Empower Pharmacy in Houston; and Red Rock Pharmacy in St. George, Utah. This provides more visibility than an unnamed partner-network claim. However, the consulted documentation does not establish which pharmacy will prepare a particular patient’s medicine or handle each formulation.
Willow attributes preparation to licensed pharmacy partners and says its compounded semaglutide is prepared by state-licensed compounding pharmacies subject to state oversight and USP standards. These remain provider descriptions rather than independent verification. Before fulfillment, patients can request the assigned pharmacy’s name, contact information and product-specific instructions. Our guide to the prescription-to-pharmacy handoff explains why identifying the dispensing pharmacy matters even when the platform collects the payment and coordinates the order.
There is also an outside-pharmacy option, but it changes the payment arrangement. Willow says it can send a prescription to a preferred pharmacy only if that pharmacy can fill the compound precisely as written. A platform fee then applies, and the patient pays the pharmacy directly for medication. The consulted pages do not quantify that fee. The advertised bundled monthly price should therefore not be assumed to carry over unchanged when a patient opts out of Willow’s partner pharmacies.
Approval, pharmacy processing and arrival run on different clocks
The most useful delivery explanation appears in Willow’s FAQ. After the physician verifies identity, reviews health history and writes the prescription, the order goes to a Willow pharmacy. Pharmacy processing takes 2–4 business days. Once shipped, delivery typically takes 2–3 days through FedEx or UPS, with possible extensions during high-volume periods. This sequence is more informative than headline references to same-day prescribing or free two-day shipping: neither means arrival two days after registration.
Willow says shipments have tracking and arrive in discreet packaging. Its FAQ lists 36 served states, rather than nationwide availability, and its terms add a location requirement: the patient must be physically in a state where the applicable practice, physician and pharmacy are authorized to provide the relevant service. Residence on the published list is therefore not the only geographic consideration. Travel or a change of location is worth raising before a consultation or refill.
For injectable deliveries, the condition of the package matters separately from its arrival date. FDA explicitly advises not using an injectable GLP-1 drug that arrives warm or with insufficient refrigeration and contacting the provider or dispensing pharmacy to resolve the concern. That is general FDA guidance, not evidence of a Willow shipping problem. Our explanation of approval, dispatch and arrival can help patients distinguish the milestones when asking Willow for an order update.
Monthly pricing follows the prescription, not just the ingredient
Willow advertises plans starting at $299 per month, including medication, medical evaluation, a treatment plan, unlimited physician access, 24/7 online care-team support and shipping. Its detailed price list nevertheless contains several higher tiers. The table below preserves the listed presentations as price identifiers, not administration instructions. Patients should obtain the exact first charge and renewal amount for their prescription; the documentation does not establish an exact supply quantity from the word “monthly” alone.
The help center’s separate $199 monthly listing concerns compounded injectable NAD+, not a $199 GLP-1 plan. Willow says HSA/FSA payment is accepted at checkout, but its insurance language conflicts. The help center suggests receipts may support possible private or employer-plan reimbursement, depending on coverage and deductible. The terms instead say patients agree not to seek reimbursement from federal or state healthcare programs or other third-party payers. That discrepancy needs written clarification before relying on reimbursement.
The consulted pages do not document a prepaid package, minimum commitment or a universal price across future prescriptions. They also do not resolve the external-pharmacy platform fee. These limits should not obscure the prices that are published: semaglutide has $299 and $399 tiers, while documented tirzepatide presentations reach $549 monthly. The practical budgeting question is which exact product and tier the physician proposes, what is included, and whether any separately prescribed medicine creates another charge.
| Product and route | Listed presentation | Monthly price |
|---|---|---|
| Semaglutide oral dissolving tablet | All listed dosages | $299 |
| Tirzepatide oral dissolving tablet | 6 mg or 10 mg; 20 mg | $399; $459 |
| Semaglutide/tirzepatide combination oral dissolving tablet | 12 mg/10 mg; 24 mg/20 mg | $399; $459 |
| Semaglutide injectable | Up to 3.5 mg; 7 mg | $299; $399 |
| Tirzepatide injectable | 2.125, 4.25 or 6.375 mg; 8.5 or 11 mg; 13.5 mg; 17 mg | $399; $499; $524; $549 |
Follow-up access is documented more clearly than its schedule
Willow advertises fully online care with free, regular follow-ups and no office visits. Its FAQ says patients typically continue with the same physician, except during vacations or staff changes, and may message that physician through the patient portal at any time. The broader support package includes video guides and a peer community. These are concrete access features, but the consulted documentation does not establish a fixed follow-up calendar or a physician response-time guarantee.
The patient-care team is a separate contact path. Willow directs users to website chat or email and says the team will respond within 24 hours; elsewhere it advertises 24/7 support. Those statements describe availability and an anticipated response window, not necessarily an immediate physician consultation. Patients should distinguish a portal message to the prescriber from a support request about billing, shipment or account access, and ask how clinical questions are escalated when a reply is needed.
Willow’s semaglutide page says a doctor may prescribe generic ondansetron if needed, but it does not establish that this optional medicine is included in the plan price. Its tirzepatide page also contains an editorial inconsistency: an adverse-effects section begins by discussing semaglutide. Neither point establishes a clinical outcome, but both support asking for product-specific counseling. NIDDK describes follow-up as assessment of tolerance and response, not merely continued payments or automatic prescription renewal.
Renewal makes the processing date a practical deadline
Willow says its program renews automatically. Although the FAQ says patients may cancel at any time by messaging the patient-care team, avoiding the next charge requires a request at least two business days before the next processing date. Requests after that cutoff apply to the following cycle. The date to confirm is therefore the processing date—not simply the expected delivery day or an assumed calendar-month anniversary.
The FAQ states that cancellation before the prescription is sent to the pharmacy qualifies for a full refund within 5–10 business days. This refund promise applies only when cancellation occurs before the prescription is sent to the pharmacy; it is not a promise that every cancellation reverses a charge. The terms also describe pharmaceutical products as nonreturnable except where legally required and refer to separate subscription, return and shipping policies whose full texts were not available in the consulted documentation.
Questions & answers
Does Willow guarantee a prescription after I pay?
No. Willow’s terms explicitly separate payment and enrollment from the physician’s prescribing decision. Intake, consultation, account registration, payment or subscription does not guarantee medication, a particular presentation or a refill. The homepage’s usual 24-hour review window concerns assessment, not guaranteed approval. Ask how a nonprescribing outcome affects any charge before completing payment.
Can I use my own pharmacy with Willow?
Willow says yes, provided the pharmacy can fill the compound precisely as its physician writes it. This route carries a platform fee, and medication is paid for directly at the outside pharmacy. The consulted pages do not state the platform fee, so request a complete quote rather than assuming the usual bundled monthly price applies.
Will my order arrive two days after approval?
That is not what the detailed timeline establishes. Willow describes 2–4 business days of pharmacy processing after the clinical steps, followed by typically 2–3 days of transportation after shipment. High-volume periods can extend timing. Tracking is advertised, but dispatch and arrival are different milestones; ask whether an update refers to prescribing, pharmacy processing or carrier transit.
Does the $299 starting price cover every Willow GLP-1 option?
No. The detailed list includes semaglutide oral dissolving tablets at $299 monthly, but other presentations cost more. Tirzepatide oral tablets are $399 or $459, and injectable tirzepatide ranges from $399 to $549 according to the listed presentation. The $199 NAD+ offering is a separate therapy, not evidence of a lower-priced GLP-1 plan.
Can I submit Willow receipts to insurance?
The public documentation gives conflicting answers. The help center describes possible reimbursement from some private or employer-designated plans, while the terms contain an agreement not to submit claims to government healthcare programs or other third-party payers. Willow does not bill insurance directly. Obtain written clarification from Willow and separately confirm your plan’s position before budgeting around reimbursement.
How do I cancel without another renewal charge?
Message Willow’s patient-care team at least two business days before the next processing date and retain confirmation. A later request applies to the following cycle under the FAQ. Cancellation alone does not establish a refund: the published full-refund condition is cancellation before the prescription is sent to the pharmacy. Confirm the order’s status and the applicable refund terms directly.
Our assessment
Willow documents a reasonably understandable online care pathway: physician-reviewed intake, prescription-dependent treatment, named pharmacy partners, tracked shipping and ongoing messaging. Its detailed processing timeline and presentation-specific prices are useful counterweights to simpler marketing headlines. The main weaknesses are unresolved insurance language, unnamed affiliated medical practices, uncertain patient-specific pharmacy assignment and limited detail about follow-up scheduling and separate policies. Before paying, obtain the exact product and monthly charge, responsible practice and pharmacy, expected processing sequence, renewal date and cancellation terms. Those confirmations would make the documented convenience easier to evaluate without mistaking platform access for a guaranteed prescription or delivery date.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Willow (startwillow.com) — en/articles/8838999 how much do treatments cost ↗
- Willow (startwillow.com) — terms of service ↗
- Willow (startwillow.com) — en/articles/8840123 who is eligible to join willow ↗
- Willow (startwillow.com) — faqs ↗
- Willow (startwillow.com) — compound semaglutide ↗
- Willow (startwillow.com) — official website ↗
- Willow (startwillow.com) — about ↗
- Willow (startwillow.com) — important safety information ↗
- Willow (startwillow.com) — compound tirzepatide ↗